DIAMEDICA THERAPEUTICS INC. (DMAC) Net income 2017–2025
DIAMEDICA THERAPEUTICS INC. (DMAC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$32.8MFY2025 · since FY2017: -$4.3M → -$32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.8M | -34.0% |
| FY2024 | -$24.4M | -26.1% |
| FY2023 | -$19.4M | -41.7% |
| FY2022 | -$13.7M | -0.6% |
| FY2021 | -$13.6M | -10.6% |
| FY2020 | -$12.3M | -15.4% |
| FY2019 | -$10.6M | -85.7% |
| FY2018 | -$5.7M | -34.6% |
| FY2017 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice